KWALITY PHARMACEUTICALS
|
The Current P/E Ratio of KWALITY PHARMACEUTICALS is 39.99.
| Share Price | ₹2,589.4 | Jul 28,2026 |
| Market Cap | ₹2,692.9 Cr | |
| Earnings-TTM | ₹67.3 Cr | TTM-Consolidated Results |
| Price/Earnings | 39.99x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of KWALITY PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹2,692.9 Cr] as on Jul 28,2026
(/) Earnings [ ₹67.3 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 39.99x ]
Thus, for KWALITY PHARMACEUTICALS , the investors are currently willing to pay 39.99 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of KWALITY PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of KWALITY PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of KWALITY PHARMACEUTICALS
PE Ratio Performance Analysis for KWALITY PHARMACEUTICALS
- KWALITY PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 13.16x.
- KWALITY PHARMACEUTICALS 's operated at median p/e ratio of 16.47x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, KWALITY PHARMACEUTICALS 's p/e ratio peaked in Mar2025 at 22.63x.
- KWALITY PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2021 of 3.84x.
How does KWALITY PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| KWALITY PHARMACEUTICALS | 67.34 | 39.99 | 2,692.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 41.02 | 474,396.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 76.71 | 196,990.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 87.16 | 186,354.0 |
| CIPLA LTD | 3,364.84 | 34.68 | 116,705.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 29.91 | 94,790.0 |
| MANKIND PHARMA LTD | 1,926.41 | 56.13 | 108,129.0 |
| LUPIN LTD | 5,355.47 | 20.45 | 109,494.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 21.82 | 109,686.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 25.48 | 89,212.3 |
| LAURUS LABS LTD | 1,090.76 | 87.08 | 94,986.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs KWALITY PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 20.45x |
| Max industry PE | 87.16x |
| Median industry PE | 39.99x |
| Average industry PE | 47.31x |
You may also like the below Video Courses